SPY335.57+1.00 0.30%
DIA278.14+3.52 1.28%
IXIC10,968.36-42.63 -0.39%

Kiniksa Pharmaceuticals Q2 EPS $(0.65) Up From $(0.68) YoY

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly losses of $(0.65) per share. This is a 4.41 percent increase over losses of $(0.68) per share from the same period last year.

Benzinga · -
Kiniksa Pharmaceuticals (NASDAQ: KNSA) reported quarterly losses of $(0.65) per share. This is a 4.41 percent increase over losses of $(0.68) per share from the same period last year.